India-focused private equity firm Everstone Group has acquired a 70% equity stake in Mumbai-based drug delivery technology firm Rubicon Research Pvt. Ltd for Rs.220 crore (about $33 million), said the company.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
